Press Releases
HANGZHOU, China, May 6, 2024 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology in China, today announced that it will report its first quarter 2024 financial results on Thursday, May 23, 2024, before the open of the U.S. markets.
The earnings teleconference call with simultaneous webcast will take place at 6:00 a.m. Eastern Time on Thursday, May 23, 2024 (Beijing/Hong Kong Time: 6:00... (continue reading...)
HANGZHOU, China, May 6, 2024 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the 2024 first quarter on Thursday, May 23, 2024, before the open of the U.S. markets.
The earnings teleconference call with simultaneous webcast will take place at 7:00 a.m. Eastern Time on Thursday, May 23, 2024 (Beijing/Hong Kong Time: 7:00... (continue reading...)
On 9 February 2024, DFDS A/S (“DFDS”) announced the initiation of a share buyback programme to be executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014, and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”).
Under the programme, DFDS will repurchase own shares of up to DKK 431m during the period from 12... (continue reading...)
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS
Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers)
Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577
DateTotal number of shares representing the share capitalTotal number of voting rightsApril, 30 20248 458 000Gross total of voting... (continue reading...)PARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in Munich and Nurnberg, Germany the first commercial doses of PYLCLARI® have been delivered. PYLCLARI® (INN: Piflufolastat (18F) also known as (18F)-DCFPyL), is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical settings:
More Press Releases
View Older Stories-
Building Turkish and USA Business relationship from Istanbul to Dallas, Texas through Selsil and Caulk Depot Plus
-
Correction: Share buy-back programme - week 18
-
Team Cymru Launches Pure Signal(TM) Scout Insight for Enhanced Proactive Security With Advanced External Threat Intelligence
-
Flash News: OKX Lists ZeroLend's Token on its Spot Market
-
Less than Half of American Adults Would Dial 911 for Stroke, Reveals New Survive Stroke Week Survey
-
Mattermost Playbooks Elevate Real-Time Cybersecurity Automation to Accelerate Compliance with New SEC & CISA Regulations
-
Wynn Resorts Releases New, Updated Images of Wynn Al Marjan Island
-
Hapag-Lloyd taps IQAX eBL to advance digital transformation of bills of lading
-
Elite Appoints New Chief Legal Officer and Corporate Secretary
-
Azure OpenAI Services Could Give Swiss Firms an AI Edge
-
Ex- DocuSign, Oracle Leader Appointed to 6sense Senior Vice President of GTM International
-
Mattermost Playbooks Elevate Real-Time Cybersecurity Automation to Accelerate Compliance with New SEC & CISA Regulations
-
Master the complexities of Pillar Two with our New Online Course!
-
Danske Bank share buy-back programme: Transactions in week 18
-
Phoenix Motor to Unveil New Branding at ACT Expo 2024
-
21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally
-
Steward Health Care Finalizing Financing Deal With Medical Properties Trust to Support Its Restructuring
-
Liquid Wind's second eFuel facility granted environmental permit
-
Alm. Brand A/S – Weekly report on share buybacks
-
Boliden: Agreement reached to reopen Tara
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Discover Unlimited Fun: Explore the Multifaceted World of JILIBET Games in The Philippines
-
Stockholm Exergi announces permanent carbon removal agreement with Microsoft, world's largest to date
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
ZTE's science-based targets approved by SBTi
-
First Hydrogen's Vehicle Trials with Multinational Company
-
IberAmerican Engages Senior Commodities Strategist
-
Successful Conclusion of SOUEAST Motor Global Investment Promotion Conference: Launching a New Chapter in Globalization Strategy
-
Reporting of transactions made by members of the Board of Directors or Executive Management or their Closely Associated Persons
-
Restructuring of ownership in BW Energy Limited and exemption from the mandatory offer obligation
-
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
-
OKX Ventures Announces Strategic Investment in EVG's Consumer-oriented Projects, Paving the Way for Novel Applications in SocialFi and GameFi
-
Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site
-
SINOX Group to Showcase the Latest Synlox e-Security System at Eurobike
-
Rimsys Launches Community-Driven Regulatory Intelligence
-
SINOX Group to Showcase Universal Laptop Locks Aligning with the AI Era at Computex Taipei 2024
-
Oma Savings Bank Plc: Manager´s Transactions – Closely associated person Tanja Mäkynen
-
Oma Savings Bank Plc: Manager´s Transactions – Jyrki Mäkynen
-
Share buy-back programme - week 18
-
Elbit Systems Schedules First Quarter 2024 Results Release For May 28, 2024
-
INRED and SES to Provide High-Throughput Connectivity Across Colombia’s Amazonas
-
LHV Pank to contest the fine decision by Estonian Financial Intelligence Unit
-
Renault Group: Communication related to the availability of the EMTN base prospectus 2024
-
Transactions in connection with share buyback programme
-
Preliminary data on early redemptions (prepayments)
-
Pierre Anjolras appointed Chief Operating Officer of VINCI
-
Marimekko celebrates the 60th anniversary of the Unikko print in Helsinki and Tokyo with public open-air fashion shows
-
QUADIENT: 2024 Financial calendar - Update
-
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
